STOCKHOLM, Feb. 9, 2026 /PRNewswire/ -- Diamyd Medical today announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for a patent covering the intralymphatic administration of retogatein (rhGAD65) with alum for the prevention and treatment of...
Hence then, the article about diamyd medical receives notice of allowance for key retogatein us patent was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Diamyd Medical receives Notice of Allowance for key retogatein US patent )
Also on site :
- Europe’s cyber agency blames hacking gangs for massive data breach and leak
- The Trump Dictatorship Is Cracking Up
- Miami lands blue-chip quarterback for 2027 class